Literature DB >> 30297877

Oxygen therapy of the newborn from molecular understanding to clinical practice.

Ola Didrik Saugstad1, Ju-Lee Oei2,3, Satyan Lakshminrusimha4, Maximo Vento5.   

Abstract

Oxygen is one of the most critical components of life. Nature has taken billions of years to develop optimal atmospheric oxygen concentrations for human life, evolving from very low, peaking at 30% before reaching 20.95%. There is now increased understanding of the potential toxicity of both too much and too little oxygen, especially for preterm and asphyxiated infants and of the potential and lifelong impact of oxygen exposure, even for a few minutes after birth. In this review, we discuss the contribution of knowledge gleaned from basic science studies and their implication in the care and outcomes of the human infant within the first few minutes of life and afterwards. We emphasize current knowledge gaps and research that is needed to answer a problem that has taken Nature a considerably longer time to resolve.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30297877     DOI: 10.1038/s41390-018-0176-8

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  11 in total

Review 1.  Intermittent hypoxemia and oxidative stress in preterm infants.

Authors:  Juliann M Di Fiore; Maximo Vento
Journal:  Respir Physiol Neurobiol       Date:  2019-05-14       Impact factor: 1.931

Review 2.  Oxygen radical disease in the newborn, revisited: Oxidative stress and disease in the newborn period.

Authors:  Marta Perez; Mary E Robbins; Cecilie Revhaug; Ola D Saugstad
Journal:  Free Radic Biol Med       Date:  2019-04-05       Impact factor: 7.376

3.  Splanchnic oxygen saturation during reoxygenation with 21% or 100% O2 in newborn piglets.

Authors:  Baukje M Dotinga; Rønnaug Solberg; Ola D Saugstad; Arend F Bos; Elisabeth M W Kooi
Journal:  Pediatr Res       Date:  2021-11-01       Impact factor: 3.953

Review 4.  Pulmonary Resilience: Moderating the Association between Oxygen Exposure and Pulmonary Outcomes in Extremely Preterm Newborns.

Authors:  Urvi Jhaveri Sanghvi; Clyde J Wright; Teri L Hernandez
Journal:  Neonatology       Date:  2022-05-12       Impact factor: 5.106

5.  Impact of Donor Human Milk in the Preterm Very Low Birth Weight Gut Transcriptome Profile by Use of Exfoliated Intestinal Cells.

Authors:  Anna Parra-Llorca; María Gormaz; Sheila Lorente-Pozo; Maria Cernada; Ana García-Robles; Isabel Torres-Cuevas; Julia Kuligoswki; Maria Carmen Collado; Eva Serna; Máximo Vento
Journal:  Nutrients       Date:  2019-11-05       Impact factor: 5.717

Review 6.  How to prevent ROP in preterm infants in Indonesia?

Authors:  Johanes Edy Siswanto; Peter H Dijk; Arend F Bos; Rita S Sitorus; Asri C Adisasmita; Sudarto Ronoatmodjo; Pieter J J Sauer
Journal:  Health Sci Rep       Date:  2021-01-18

7.  A Novel Association between YKL-40, a Marker of Structural Lung Disease, and Short Telomere Length in 10-Year-Old Children with Bronchopulmonary Dysplasia.

Authors:  Ewa Henckel; Anna James; Jon R Konradsen; Björn Nordlund; Malin Kjellberg; Eva Berggren-Broström; Gunilla Hedlin; Sofie Degerman; Kajsa Bohlin
Journal:  Children (Basel)       Date:  2021-01-24

8.  Oxygen saturation after birth in resuscitated neonates in Uganda: a video-based observational study.

Authors:  Mårten Larsson; Susanna Myrnerts Höök; Allan Mpamize; Thorkild Tylleskär; Clare Lubulwa; Daniele Trevisanuto; Kristina Elfving; Nicolas J Pejovic
Journal:  BMJ Paediatr Open       Date:  2022-01

Review 9.  Oxygen Toxicity to the Immature Lung-Part I: Pathomechanistic Understanding and Preclinical Perspectives.

Authors:  Yesi Choi; Lisa Rekers; Ying Dong; Lena Holzfurtner; Maurizio J Goetz; Tayyab Shahzad; Klaus-Peter Zimmer; Judith Behnke; Jonas Behnke; Saverio Bellusci; Harald Ehrhardt
Journal:  Int J Mol Sci       Date:  2021-10-12       Impact factor: 5.923

Review 10.  Optimizing oxygen therapy for preterm infants at birth: Are we there yet?

Authors:  Vishal Kapadia; Ju Lee Oei
Journal:  Semin Fetal Neonatal Med       Date:  2020-01-16       Impact factor: 3.926

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.